The world has yet to see a form of the deadly bird flu virus that could spread easily between people and cause a global outbreak - but that doesn't mean it won't happen, scientists said on Thursday.
After studying 15 years of data on bird flu viruses in the wild, researchers said some strains were already part way along the road to acquiring a handful of mutations needed to change into a form that could cause a devastating human pandemic.
"The remaining... mutations could evolve in a single human host, making a virus evolving in nature a potentially serious threat," Derek Smith of Britain's University of Cambridge, who led the research, told reporters.
Currently, bird flu, or H5N1 avian flu, can be transmitted from birds to birds, and birds to humans, but not from humans to humans. When it does pass from birds to humans, it is usually fatal.
Two earlier studies by researchers in the United States and Europe have found that with as few as five mutations, H5N1 flu can become transmissible in the air between mammals, including potentially from person to person.
Their work was highly controversial because they manipulated viruses in the lab to produce the new mutated strains.
Mutations are already out there
Until now, scientists were not sure whether it was possible these same mutations could evolve in nature.
But Smith's co-researcher Colin Russell said their study, published on Thursday in the journal Science, showed it was.
"Viruses that have two of these mutations are already common in birds, meaning that there are viruses that might have to acquire only three additional mutations in a human to become airborne transmissible," he told reporters.
So far, the H5N1 virus, which was first detected in Hong Kong in 1997, has infected tens of millions of ducks, geese, chickens and other birds. People who have been infected - so far there have been 606, of whom 357 have died - are mostly those who came into close contact with birds.
Last year, teams led by Ron Fouchier at Erasmus Medical Center and by Yoshihiro Kawaoka at the University of Wisconsin managed to create laboratory-enhanced versions of the virus that spread like ordinary flu between mammals.
This type of research is seen as vital for scientists working to develop vaccines, diagnostic tests and anti-viral drugs that could be deployed in the event of an H5N1 pandemic.
But opponents said the work could be misused by terrorists or that the virus might somehow escape from the lab and spread. An international row over the publication of the two papers blew up, leading to a temporary moratorium on such research.
"Active fault line"
Smith likened scientists' current position on the likelihood of an H5N1 human pandemic to that of researchers trying to predict an earthquake.
"We now know that we're living on a fault line," he said. "And what we have discovered in this working collaboration with Fouchier and Kawaoka is that it's an active fault line. It really could do something. We've seen no fundamental hurdle to that happening."
But he said it was impossible to assess the exact risk. "We know it is in the realms of possibility ... and what needs to be done now is to assess the risk more accurately."
In a second H5N1 study published as part of a series on bird flu in Science on Thursday, Rino Rappuoli, a researcher at the Swiss drugmaker Novartis's vaccines and diagnostics unit in Italy, outlined how the world could better prepare for a potential bird flu pandemic.
Among the most important steps, he said, would be to immunise as many people as possible with existing H5N1 vaccines to prime their immune systems and reduce the severity of illness if a pandemic were to happen. There was also a need to ensure manufacturers could make large quantities of a pandemic vaccine quickly by sharing strains and scientific knowledge swiftly across the world.
Soon more than 1 billion consumers in developing nations will be able to buy their first air conditioner, increasing energy demand which will impact global warming
The European Union has given new authorization for 10 new types of genetically modified crops have been approved for a 10 year use for human consumption and animal feed.
Guinea's President Alpha Conde announced new emergency measures in Ebola fight on Saturday
'Meetings happened. Action didn’t,' says Medecins Sans Frontieres report.
WHO said that on many levels, the world is better prepared now than ever before for aflu pandemic
Myanmar health officals say an outbreak of H5N1 bird flu in Mandalay
Tokyo Electric said it has been aware since last spring that radiation levels in water running in one of the plant gutters rise when it rains
Safe drinking water is available at about one-third of the level it was before the conflict erupted nearly five years ago, and supplies are cut-off to punish civilians at times
Elephants in Angola, which suffered decades of civil war, have been observed avoiding heavily-mined areas, suggesting their trunks were warning them to stay away.
Favipiravir halved death rate among some to 15 pct, but WHO says more research required on drug
The first medicine containing stem cells to treat a rare condition caused by burns to the eye has approved.
940 parasite samplescollected at 55 malaria treatment centres across Myanmar and its border regions. They found that almost 40 percent of the samples had mutations in their so-called kelch gene, K13 -- a known genetic signal of artemisinin drug resistance.
Yaws is known to be prevalent in 12 countries in areas where people have little access to healthcare, mainly in West and Central Africa, Asia and the Pacific Islands.
In the past few years, Nepal has seen the numbers of endangered species, such as the Royal Bengal tiger or the one-horned rhino, rise.
The investment would represent as little as 0.1 percent of current national health spending of the low and middle-income countries affected by NTD.
Nearly 1,000 abandoned California sea lions have washed ashore this year in what rehabilitation centers say is a growing crisis for the animals.